Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Engineered immune cells get a helping hand in a new clinical trial for multiple myeloma patients.
The approval is based on data from CASSIOPEIA, an open-label, randomized, active-controlled phase 3 study.
September was designated as National Blood Cancer Awareness Month in 2010 by United States Congress.
The Affordable Care Act erases racial disparities in care for advanced cancers.
Even cancer that doesn’t affect the bones directly can contribute to bone problems.
“What was unique in this study was that in the VA, everybody is equal, and everyone gets the same access to drugs.”
Investigators say their findings support annual blood tests for all individuals with MGUS.
In 2009, March was declared Myeloma Awareness Month (MAM).
The PROMISE study aims to identify people with conditions that are precursors of multiple myeloma and track their health over time.
First nuclear export inhibitor gets the nod for patients lacking treatment options.
Here’s a list of the approved drugs to treat multiple myeloma. Click on any of the medications for more info on dosing, side effects...
Darzalex in combination with lenalidomide and dexamethasone is for people who are ineligible for an autologous stem cell transplant.
An advanced study compared intravenous infusions and subcutaneous injections of the antibody treatment.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.